RecruitingNot ApplicableNCT07270016

Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes: Pilot Study

Sponsor

University of Pittsburgh

Enrollment

30 participants

Start Date

Feb 16, 2026

Study Type

INTERVENTIONAL

Conditions

Physical Inactivity Diabetes Mellitus, Type 2 Hyperglycemia Continuous Glucose Monitoring Lifestyle (Sedentary Behavior and Physical Activity)

Summary

The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking participants aged 16-24 years who were diagnosed with type 2 diabetes before age 18. Participants will be asked to fill out surveys about diabetes, physical activity, and diet before and after wearing a CGM for 30 days. At the end of wearing the CGM, participants will complete an interview about their experience.

Eligibility

Min Age: 16 YearsMax Age: 24 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a real-time digital coaching program to help young people aged 16–24 who were diagnosed with type 2 diabetes before age 18 better manage their blood sugar. Participants will use an app along with a continuous glucose monitor (a small sensor that tracks blood sugar automatically). **You may be eligible if...** - You are between 16 and 24 years old - You were diagnosed with type 2 diabetes before age 18 - You speak English - You own a smartphone compatible with the FreeStyle Libre app **You may NOT be eligible if...** - You have a cognitive impairment that prevents app use - You have a severe psychiatric condition - You are currently pregnant - You do not have access to a compatible smartphone Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHealthmine app

Participants will wear study-provided continuous glucose monitoring device and Fitbit physical activity tracker for 30 consecutive days. During the same period, they will use an investigator-developed smartphone app (Healthmine), which is being developed to pair CGM and Fitbit data. Participants will receive up to one message about health behavior change (e.g., physical activity, nutrition) daily and will be able to use Healthmine to log exercise and dietary intake.